New Drug
-
{
- All
- News
- Videos
- Web Stories
-
Anti-Obesity Market Booms: 1 In 8 Americans Turn To GLP-1 Drugs For Weight Loss
- Wednesday May 6, 2026
- Author: NDTV Profit News, Edited by: NDTV Business Desk
GLP-1 drugs see rapid uptake in the US, with rising acceptance as a mainstream treatment for obesity despite lingering hesitation among some groups.
-
www.ndtvprofit.com
-
Granules India Gets US FDA Nod For Tablets To Treat Major Depressive Disorder
- Friday October 18, 2024
- Author: Shreya Sur
The tablet that received the approval is therapeutically equivalent to Wellbutrin SR sustained-release tablets, 100 mg, 150 mg, and 200 mg, by GlaxoSmithKline LLC, an exchange filing said.
-
www.ndtvprofit.com
-
Granules India Gets US FDA Nod For Tablets To Treat Major Depressive Disorder
- Friday October 18, 2024
- Author: Shreya Sur
The tablet that received the approval is therapeutically equivalent to Wellbutrin SR sustained-release tablets, 100 mg, 150 mg, and 200 mg, by GlaxoSmithKline LLC, an exchange filing said.
-
www.ndtvprofit.com
-
Alembic Pharma Gets US FDA Nod For Generic Medication To Treat Seizure
- Thursday October 3, 2024
- Author: Shreya Sur
Lamotrigine extended-release tablets have an estimated market size of $163 million, as per data for twelve months ending June 2024, according to IQVIA.
-
www.ndtvprofit.com
-
Dr Reddy's Labs Gains on Filing 3 New Drug Applications
- Friday December 8, 2023
- Author: NDTV Profit Desk
The Hyderabad-based firm and its subsidiary - Promius Pharma LLC - have filed three new drug applications with the US health regulator, Dr Reddy's Laboratories said in a statement.
-
www.ndtvprofit.com
-
Lupin Gets Final Nod From USFDA For Birth Control Pill
- Friday December 8, 2023
- Author: Press Trust of India
Lupin has received final approval from the US health regulator for marketing Norgestimate and Ethinyl Estradiol tablets in the US market.
-
www.ndtvprofit.com
-
Lupin Gets USFDA Nod For Generic Pain Relieving Drug
- Friday December 8, 2023
- Author: Press Trust of India
Currently, Lupin has the fifth largest pipeline of abbreviated new drug application (ANDA) filings pending approval with the USFDA.
-
www.ndtvprofit.com
-
Lupin Launches Bacterial Infection Treatment Drug in US Market
- Thursday December 7, 2023
- Author: NDTV Profit Desk
Drug firm Lupin Ltd has launched its generic Ciprofloxacin, used for treating bacterial infections, in the American market and is expecting 180 days of market exclusivity.
-
www.ndtvprofit.com
-
Nine New Drugs Under Clinical Stage: Dr Reddy's
- Thursday December 7, 2023
- Author: NDTV Profit Desk
According to a filing with US SEC, the drug maker said as of March 31, 2014, DRL had 20 active products in the proprietary products pipeline, of which nine were in clinical development stage.
-
www.ndtvprofit.com
-
New Drug Identified May Help Effectively Treat COVID-19 Pneumonia: Lancet Study
- Saturday December 18, 2021
- Science | Press Trust of India
A newly identified drug may be used to effectively treat some patients hospitalised with COVID-19 pneumonia, according to a study published in The Lancet Respiratory Medicine journal.
-
www.ndtv.com
-
New Drug Combination Found Effective Against COVID-19 Infection: Study
- Friday October 1, 2021
- Science | Press Trust of India
A new drug combination can suppress infection by the S-CoV-2 virus, which causes COVID-19, according to a study conducted in animals and cell cultures.
-
www.ndtv.com
-
Anti-Obesity Market Booms: 1 In 8 Americans Turn To GLP-1 Drugs For Weight Loss
- Wednesday May 6, 2026
- Author: NDTV Profit News, Edited by: NDTV Business Desk
GLP-1 drugs see rapid uptake in the US, with rising acceptance as a mainstream treatment for obesity despite lingering hesitation among some groups.
-
www.ndtvprofit.com
-
Granules India Gets US FDA Nod For Tablets To Treat Major Depressive Disorder
- Friday October 18, 2024
- Author: Shreya Sur
The tablet that received the approval is therapeutically equivalent to Wellbutrin SR sustained-release tablets, 100 mg, 150 mg, and 200 mg, by GlaxoSmithKline LLC, an exchange filing said.
-
www.ndtvprofit.com
-
Granules India Gets US FDA Nod For Tablets To Treat Major Depressive Disorder
- Friday October 18, 2024
- Author: Shreya Sur
The tablet that received the approval is therapeutically equivalent to Wellbutrin SR sustained-release tablets, 100 mg, 150 mg, and 200 mg, by GlaxoSmithKline LLC, an exchange filing said.
-
www.ndtvprofit.com
-
Alembic Pharma Gets US FDA Nod For Generic Medication To Treat Seizure
- Thursday October 3, 2024
- Author: Shreya Sur
Lamotrigine extended-release tablets have an estimated market size of $163 million, as per data for twelve months ending June 2024, according to IQVIA.
-
www.ndtvprofit.com
-
Dr Reddy's Labs Gains on Filing 3 New Drug Applications
- Friday December 8, 2023
- Author: NDTV Profit Desk
The Hyderabad-based firm and its subsidiary - Promius Pharma LLC - have filed three new drug applications with the US health regulator, Dr Reddy's Laboratories said in a statement.
-
www.ndtvprofit.com
-
Lupin Gets Final Nod From USFDA For Birth Control Pill
- Friday December 8, 2023
- Author: Press Trust of India
Lupin has received final approval from the US health regulator for marketing Norgestimate and Ethinyl Estradiol tablets in the US market.
-
www.ndtvprofit.com
-
Lupin Gets USFDA Nod For Generic Pain Relieving Drug
- Friday December 8, 2023
- Author: Press Trust of India
Currently, Lupin has the fifth largest pipeline of abbreviated new drug application (ANDA) filings pending approval with the USFDA.
-
www.ndtvprofit.com
-
Lupin Launches Bacterial Infection Treatment Drug in US Market
- Thursday December 7, 2023
- Author: NDTV Profit Desk
Drug firm Lupin Ltd has launched its generic Ciprofloxacin, used for treating bacterial infections, in the American market and is expecting 180 days of market exclusivity.
-
www.ndtvprofit.com
-
Nine New Drugs Under Clinical Stage: Dr Reddy's
- Thursday December 7, 2023
- Author: NDTV Profit Desk
According to a filing with US SEC, the drug maker said as of March 31, 2014, DRL had 20 active products in the proprietary products pipeline, of which nine were in clinical development stage.
-
www.ndtvprofit.com
-
New Drug Identified May Help Effectively Treat COVID-19 Pneumonia: Lancet Study
- Saturday December 18, 2021
- Science | Press Trust of India
A newly identified drug may be used to effectively treat some patients hospitalised with COVID-19 pneumonia, according to a study published in The Lancet Respiratory Medicine journal.
-
www.ndtv.com
-
New Drug Combination Found Effective Against COVID-19 Infection: Study
- Friday October 1, 2021
- Science | Press Trust of India
A new drug combination can suppress infection by the S-CoV-2 virus, which causes COVID-19, according to a study conducted in animals and cell cultures.
-
www.ndtv.com